Trial Profile
Prospective, multicenter study investigating correlation between LDL-C levels and treatment outcomes from Telaprevir (TVR) based therapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Dec 2015
Price :
$35
*
At a glance
- Drugs Telaprevir (Primary) ; Peginterferon alfa-2b; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- 21 Dec 2015 New trial record